Europe Sinus Tissue Resection Market (By Product: Endoscopes, Ethmoid Forceps, Nasal Scissors, Curetts; By End-use; By Country) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The Europe sinus tissue resection market size was estimated at around USD 153.06 million in 2021 and it is projected to hit around USD 263.81 million by 2030, growing at a CAGR of 6.24% from 2022 to 2030

Report Highlights

• The endoscopes segments held the largest revenue share of over 30.06% in 2021.
• The currets segment is expected to expand at a CAGR of 6.44% during the assessment period. 
• The hospital segment accounted for the largest revenue share of over 30.05% in 2021.
• The ambulatory surgical centers segment is expected to expand at a significant CAGR of 6.41% during the forecast years. 
• Germany held the largest revenue share of over 15.18% in 2021. 
• Switzerland is expected to witness significant growth during the projection period.

 The rise in the prevalence of chronic sinusitis, rising preference for minimally invasive surgeries, and technological advancements are expected to propel the growth of the industry during the forecast period. Although the market witnessed a significant fall in the sales of sinus tissue resection products, it is expected to recover and flourish during the projection period. The lockdowns and restrictions resulted in a reduced number of elective surgeries, which further led to a fall in the sales of sinus tissue resection products.

Most countries in Europe specifically observed a major loss of life and financial losses due to the pandemic. Countries like Italy, which have a huge geriatric population, were badly hit by the virus, and recovering from it has been difficult. However, with the European countries now focusing on their healthcare systems more than ever before, the region is trying its best to combat similar situations in the near future. With the conduction of mass vaccination programs, the opening of the economies, and economic activities resuming, the market has already started to recover.

The increasing prevalence of chronic sinusitis is among the major factors anticipated to positively contribute to the industry growth. As per the National Institute for Health and Care Excellence, chronic sinusitis is a common condition in Europe and affects 1 in 10 adults in the U.K. Additionally, according to the European Forum for Research and Foundation in Allergy and Airway Diseases, around 10% of the population is suffering from chronic rhinitis across the European region.

Scope of The Report

Product Insights

The endoscopes segments held the largest revenue share of over 30.06% in 2021. Endoscopes help in improving airflow through the nose and symptoms associated with sinuses. They also help in the reduction and severity of sinus infections, thus making it the leading segment in terms of revenue, and this trend is expected to continue during the forecast period. Based on product, the market is segmented into endoscopes, ethmoid forceps, nasal scissors, currets, and others.                                            

The currets segment is expected to expand at a CAGR of 6.44% during the assessment period. This is attributed to the availability of various shapes of the blades, which expands the application scope for a large number of indications. The growing prevalence of chronic sinusitis and more number of people opting for sinus tissue resection procedures are further expected to fuel the growth of currets in the coming years.

End-use Insights

The hospital segment accounted for the largest revenue share of over 30.05% in 2021 owing to a large number of procedures being performed in hospitals and the continued preference of patients to visit hospitals in comparison to other settings. This is, in turn, making it the dominant segment in terms of end-use. On the basis of end-use, the market is fragmented into hospitals, ambulatory surgical centers, clinics, and others.

The ambulatory surgical centers segment is expected to expand at a significant CAGR of 6.41% during the forecast years. This is because of the advantages associated with ambulatory surgical centers such as reduced in-patient time, which reduces the overall cost incurred on the additional stay post surgeries. Moreover, a rise in the number of new ambulatory surgical centers in the region is boosting the segment growth.

Country Insights

Germany held the largest revenue share of over 15.18% in 2021. Factors contributing to the market growth in the country include a well-established healthcare infrastructure and system, increasing prevalence of allergic rhinitis in the country, and easy availability of the products. For instance, according to a research article published in World Allergy Organization Journal, in 2018, Germany observed a high prevalence of allergies in the country, with about 20% of its population having at least one allergy and only about 10% opting to adequately treat it.

Switzerland is expected to witness significant growth during the projection period due to the country’s increased focus on the healthcare and medical device industries. The country is one of the most important locations for the medical device industry. This makes Switzerland a very attractive market.

Key Players

• Medtronic
• Intellus Medical, Inc.
• B.Braun Melsungen
• Integra Lifesciences
• Karl Storz
• Bausch & Lomb Incorporated

Market Segmentation

• By Product Outlook

• Endoscopes
• Ethmoid Forceps
• Nasal Scissors
• Curetts
• Others
• By End-use Outlook
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others
• By Country Outlook
• U.K.
• Germany
• France
• Italy
• Spain
• Switzerland
• Israel
• Sweden
• Norway
• Greece
• Austria
• Netherlands
• Portugal
• Luxembourg
• Denmark
• Iceland
• Ireland
• Belgium
• Finland